Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1/2 Study of 124I-NM404 in Subjects With Advanced Solid Malignancies

Trial Profile

A Phase 1/2 Study of 124I-NM404 in Subjects With Advanced Solid Malignancies

Status: Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 14 Jan 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs CLR 1404 I-124 (Primary)
  • Indications Brain metastases; Colorectal cancer; Gastric cancer; Head and neck cancer; Oesophageal cancer; Ovarian cancer; Pancreatic cancer; Prostate cancer; Soft tissue sarcoma
  • Focus Diagnostic use
  • Most Recent Events

    • 16 May 2016 Status changed from active, no longer recruiting to discontinued as sponsor determined this trial does not support their anticipated clinical development program.
    • 21 Aug 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
    • 30 Apr 2015 Status changed from suspended to recruiting as reported by ClinicalTrials.gov
Restricted Access

If your organization has a subscription then there are several options available to help you access AdisInsight while working remotely. Contact us at AsktheExpert.AdisInsight@springer.com to find out more.
Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top